ADMA Biologics (ADMA)
US Market

ADMA Biologics Balance Sheet


ADMA Biologics Balance Sheet

ADMA Biologics's total assets for Q3 2022 were $300.56M, an increase of 1.22% from the previous quarter. ADMA total liabilities were $200.17M for the fiscal quarter, a 9.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Assets
$ 276.25M$ 207.67M$ 127.09M$ 88.88M$ 108.02M
Total Liabilities
$ 135.08M$ 119.42M$ 100.90M$ 69.11M$ 67.69M
Total Equity Gross Minority
$ 141.17M$ 88.25M$ 26.19M$ 19.77M$ 40.33M
Total Capitalization
$ 236.04M$ 181.22M$ 109.39M$ 63.85M$ 83.30M
Preferred Stock Equity
Capital Lease Obligations
$ 8.05M$ 4.70M$ 1.53M$ 149.06K$ 0.00
Currency in USD

ADMA Biologics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis